Options Trading Highlights in Russell 3000: Altimmune, Duolingo, AMD
Today, several companies within the Russell 3000 index displayed significant options trading activity. Notably, Altimmune Inc (Symbol: ALT) recorded a trading volume of 15,292 contracts, translating to approximately 1.5 million underlying shares. This figure represents about 74.3% of ALT’s average daily trading volume of 2.1 million shares over the past month. The $10 strike call option, set to expire on June 20, 2025, was particularly active, with 2,588 contracts exchanged today—equating to about 258,800 underlying shares. Below is a chart illustrating ALT’s trailing twelve-month trading history, with the $10 strike highlighted in orange:
Duolingo Inc (Symbol: DUOL) also experienced robust options trading, with a volume of 6,373 contracts, representing about 637,300 underlying shares. This totals approximately 69.7% of DUOL’s average daily trading volume of 913,750 shares over the last month. The $300 strike put option expiring on May 16, 2025, drew significant interest, with 516 contracts traded today, corresponding to around 51,600 underlying shares. Below is a chart depicting DUOL’s trailing twelve-month trading history, with the $300 strike highlighted in orange:
Advanced Micro Devices Inc (Symbol: AMD) registered a staggering options trading volume of 318,678 contracts, which equates to approximately 31.9 million underlying shares. This volume represents about 69.2% of AMD’s average daily trading volume of 46.1 million shares in the past month. A strong interest was noted in the $100 strike call option expiring on May 02, 2025, with 47,030 contracts traded today, translating to around 4.7 million underlying shares. Below is a chart showcasing AMD’s trailing twelve-month trading history, with the $100 strike highlighted in orange:
For a comprehensive list of available expiration dates for options on ALT, DUOL, or AMD, please visit StockOptionsChannel.com.
Today’s Most Active Call & Put Options of the S&P 500 »
The views and opinions expressed herein are those of the author and do not necessarily reflect those of Nasdaq, Inc.








